We also demonstrated that inhibition of RIP2 by GSK559, a small molecule inhibitor, improved the ischemic stroke outcomes, while OTUD1 deficiency exacerbated cerebral ischemic injury. The gene discussed is RIPK2; the disease is ischemic stroke.